Cargando…

A Systematic Review and Individual Patient Data Network Analysis of the Residual Symptom Structure Following Cognitive-Behavioral Therapy and Escitalopram, Mirtazapine and Venlafaxine for Depression

OBJECTIVE: Consistent evidence suggests residual depressive symptomology are the strongest predictors of depression relapse following cognitive-behavioral therapy (CBT) and antidepressant medications (ADM's). Psychometric network models help detecting and understanding central symptoms that rem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whiston, Aoife, Lennon, Amy, Brown, Catherine, Looney, Chloe, Larkin, Eve, O'Sullivan, Laurie, Sik, Nurcan, Semkovska, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843824/ https://www.ncbi.nlm.nih.gov/pubmed/35178002 http://dx.doi.org/10.3389/fpsyt.2022.746678

Ejemplares similares

Mirtazapine Creating “Miracles” in Psychotic Depression With Catatonia
por: Patel, Rikinkumar S, et al.
Publicado: (2020)

Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
por: Gahr, Maximilian, et al.
Publicado: (2020)

Venlafaxine as an Adjuvant Therapy for Inflammatory Bowel Disease Patients With Anxious and Depressive Symptoms: A Randomized Controlled Trial
por: Liang, Chang, et al.
Publicado: (2022)

Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram
por: Toshida, Masamitsu, et al.
Publicado: (2021)

Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice
por: Sikka, Pranav, et al.
Publicado: (2011)

Chronic treatment with escitalopram and venlafaxine affects the neuropeptide S pathway differently in adult Wistar rats exposed to maternal separation
por: Gołyszny, Miłosz, et al.
Publicado: (2022)

Differential Effects of Single-Dose Escitalopram on Cognitive and Affective Interference during Stroop Task
por: Rahm, Christoffer, et al.
Publicado: (2014)

Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis
por: Furukawa, Toshi A, et al.
Publicado: (2019)

An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder
por: Santi, N Simple, et al.
Publicado: (2023)

Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study
por: Woo, Young Sup, et al.
Publicado: (2017)

Regional White Matter Integrity Predicts Treatment Response to Escitalopram and Memantine in Geriatric Depression: A Pilot Study
por: Krause-Sorio, Beatrix, et al.
Publicado: (2020)

Cardiovascular adverse reactions associated with escitalopram in patients with underlying cardiovascular diseases: a systematic review and meta-analysis
por: Kimura, Kenichi, et al.
Publicado: (2023)

Metoprolol, N-Acetylcysteine, and Escitalopram Prevents Chronic Unpredictable Mild Stress-Induced Depression by Inhibition of Endoplasmic Reticulum Stress
por: Yang, Lixia, et al.
Publicado: (2018)

Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy
por: Eichentopf, Luzie, et al.
Publicado: (2022)

Mirtazapine for symptom control in refractory gastroparesis
por: Malamood, Mark, et al.
Publicado: (2017)

Development and Internal Validation of a Novel Model to Identify Inflammatory Biomarkers of a Response to Escitalopram in Patients With Major Depressive Disorder
por: Zhou, Jingjing, et al.
Publicado: (2021)

Venlafaxine-induced psychotic symptoms
por: Safeekh, A. T., et al.
Publicado: (2009)

A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine
por: Li, Zhe, et al.
Publicado: (2023)

Label-Free Liquid Chromatography–Mass Spectrometry Proteomic Analysis of the Urinary Proteome for Measuring the Escitalopram Treatment Response From Major Depressive Disorder
por: Huan, Yuhang, et al.
Publicado: (2021)

Intramuscular ketamine vs. escitalopram and aripiprazole in acute and maintenance treatment of patients with treatment-resistant depression: A randomized double-blind clinical trial
por: Cigognini, Marco Aurélio, et al.
Publicado: (2022)

Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report
por: Wu, Jianhong, et al.
Publicado: (2023)

Behavioral, cortical and autonomic effects of single-dose escitalopram on the induction and regulation of fear and disgust: Comparison with single-session psychological emotion regulation with reappraisal
por: Sklivanioti Greenfield, Myrto, et al.
Publicado: (2023)

Mirtazapine for Refractory Gastroparesis
por: Marella, Hemnishil K., et al.
Publicado: (2019)

Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder
por: François, C, et al.
Publicado: (2008)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Transcutaneous Electrical Cranial-Auricular Acupoint Stimulation vs. Escitalopram for Patients With Mild-to-Moderate Depression (TECAS): Study Design for a Randomized Controlled, Non-inferiority Trial
por: Yang, Sichang, et al.
Publicado: (2022)

What is the effectiveness and safety of mirtazapine versus escitalopram in alleviating cancer-associated poly-symptomatology (the MIR-P study)? A mixed-method randomized controlled trial protocol
por: Economos, Guillaume, et al.
Publicado: (2022)

Efficacy and Safety of Escitalopram Oral Drops to Treat Major Depressive Disorder and Generalized Anxiety Disorder in Adolescent, Adult and Geriatric Patients: A Prospective Multicenter Observational Study in Pakistan
por: Afridi, Muhammad Iqbal, et al.
Publicado: (2020)

Mirtazapine withdrawal-induced mania
por: Verma, Jitendra Kumar, et al.
Publicado: (2015)

Tachyphylaxis to the Sedative Action of Mirtazapine
por: Papazisis, Georgios, et al.
Publicado: (2018)

Mirtazapine for the Treatment of Chronic Pruritus
por: Khanna, Raveena, et al.
Publicado: (2019)

Nightmares and Mirtazapine—Time to be vigilant
por: Sudha TY, Sree, et al.
Publicado: (2020)

PS213. Pharmacokinetics of mirtazapine and its hydroxylated metabolite in Japanese psychiatric patients treated with mirtazapine
por: Watanabe, Takashi, et al.
Publicado: (2016)

VENLAFAXINE-INDUCED MANIA
por: Jagadheesan, K., et al.
Publicado: (2001)

Venlafaxine besylate monohydrate
por: Corvalan, Carolina H., et al.
Publicado: (2013)

Kleptomania Induced by Venlafaxine
por: Sakurada, Kumi, et al.
Publicado: (2021)

Venlafaxine-induced hypoglycemia
por: Kobylianskii, Jane, et al.
Publicado: (2021)

Escitalopram-induced hepatitis: A case report
por: Wabont, Guillaume, et al.
Publicado: (2022)

Mirtazapine-associated hyponatremia presenting as delirium
por: Ghosh, Abhishek, et al.
Publicado: (2014)

Mirtazapine-induced acute angle closure
por: Kahraman, Nilay, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jeoa6vdtj3der4j98ovjjuqe8p